Journal of Korean Traditional Oncology (대한암한의학회지)

Korean Association of Traditional Oncology (대한암한의학회)
권호 표지
DOI QR코드

DOI QR Code

A Review of Korean Medicine for Clinical Practice Guidelines for Cervical Cancer

자궁경부암의 한의학적 진료에 대한 고찰

  • Jung, Hyun-Jung (Department of Diagnotics, Deagu hanny University) ;
  • Yoo, Hwa-seung (East-west cancer ceneter, Dunsan Korean Medicine Hospital of Daejeon University)
  • Received : 2016.05.02
  • Accepted : 2016.06.10
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The incidence rate of cervical cancer in Korea is still higher than in other developed countries, notwithstanding the national mass screening program. Cervical cancer prognosis is good due to an effective treatment such as surgery or radiation therapy, concurrent chemotherapy in the early stage. However, it is still a poor prognosis when advanced stage or recurrent. Some studies said that combined oriental and western medicine can improve the survival, quality of life, immune function, and decrease side effects in cervical cancer. In the western medical part, clinical practice guideline was published in 2006, 2007 and 2010 in Korea. In China, oriental medicine clinical practice guideline have been published in 2014. But there is no Korean medicine clinical practice guideline. This study will introduce the methods of diagnosis and the medical therapeutics which is commonly utilized for cervical cancer in Korea, and existing Korean medicine clinical practice guideline for Disease Analysis and Treatment (辨證論治). This study will be a meaningful study to establish clinical practice guidelines of Korean Medicine for cervical cancer.

Keywords

References

  1. 국가암정보센터 http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040402000000
  2. DeSouza NM, Whittle M, Williams AD, Sohail M, Krausz T, Gilderdale DJ, et al. Magnetic resonance imaging of the primary site in stage I cervical carcinoma: a comparison of endovaginal coil with external phased array coil techniques at 0.5T. J Magn Reson Imaging 2000; 12: 1020-6 https://doi.org/10.1002/1522-2586(200012)12:6<1020::AID-JMRI30>3.0.CO;2-T
  3. Smith AM, Heywood W, Ryall R, Shelley JM, Pitts MK, Richters J, Simpson JM, Patrick K. Association between sexual behavior and cervical cancer screening. J Woman Health (Larchmt) . 2011;20(7): 1091-6 https://doi.org/10.1089/jwh.2010.2585
  4. Zhang B, Zou AF, Zhu CC, Zhang YQ, Xiang B, Chen Z, Hu RH, Zhang YQ, Qiu L, Zhang YM, Xiong CD, Du YK Shi YQ. Risk factors for cervical cancer in rural areas of Wuhan China : a matched case-control study. Asian Pac J Cancer Prev. 2013; 14(12): 7595-600 https://doi.org/10.7314/APJCP.2013.14.12.7595
  5. 임명철, 이선경, 박성재, 김승보. 자궁경부암 환자의 임상병리학적 분석 및 예후에 관한 연구. 대한산부인과학회지. 2005;48(2):304-13
  6. Kim BJ, Moon G, An Outlook of the Oriental and Western Medical Diagnosis an Treatment on Gastric cnaer. K.O.M.S. 1996:17(2);100-16.
  7. 林洪生. 惡性腫瘤中醫診療指南. 북경인민위생출판사. 2014:471-98.
  8. 자궁경부암 진료 권고안 ver 2.0 2010
  9. Desouza NM, Dina R, Mcindoe GA, Soutter WP. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension. Gynecol Oncol 2006; 102: 80-5 https://doi.org/10.1016/j.ygyno.2005.11.038
  10. Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005; 23: 9329-37 https://doi.org/10.1200/JCO.2005.02.0354
  11. Elit L, Fyles AW, Devries MC, Oliver TK, Fung-Kee-Fung M; Gynecology Cancer Disease Site Group. Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol 2009; 114(3): 528-35 https://doi.org/10.1016/j.ygyno.2009.06.001
  12. 鬱仁存, 王笑民. 21世紀中西醫結合腫瘤硏究前瞻. 中醫雜誌. 2001; 42(1): 50-52,
  13. Bansal N, Herzog TJ, Shaw RE, Burke WM, Deutsch I, Wright JD. Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obstet Gynecol. 2009;201(5):485.e1-9 https://doi.org/10.1016/j.ajog.2009.06.015
  14. Koliopoulos G, Sotiriadis A, Kyrgiou M, Martin-Hirsch P, Makrydimas G, Paraskevaidis E. Conservative surgical methods for FIGO stage IA2 squamous cervical carcinoma and their role in preserving women's fertility. Gynecol Oncol 2004; 93(2): 469-73 https://doi.org/10.1016/j.ygyno.2004.02.002
  15. Bekkers RL, Keyser KG, Bulten J, Hanselaar AG, Schijf CP, Boonstra H, et al. The value of loop electrosurgical conization in the treatment of stage IA1 microinvasive carcinoma of the uterine cervix. Int J Gynecol Cancer 2002; 12(5): 485-9. 12. https://doi.org/10.1046/j.1525-1438.2002.01131.x
  16. Itsukaichi M, Kurata H, Matsushita M, Watanabe M, Sekine M, Aoki Y, et al. Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins. Gynecol Oncol 2003; 90(2): 387-9. https://doi.org/10.1016/S0090-8258(03)00333-0
  17. Mota F. Microinvasive squamous carcinoma of the cervix: treatment modalities. Acta Obstet Gynecol Scand 2003; 82(6): 505-9. https://doi.org/10.1034/j.1600-0412.2003.00124.x
  18. Bernardini M, Barrett J, Seaward G, Covens A. Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol 2003; 189(5): 1378-82. https://doi.org/10.1067/S0002-9378(03)00776-2
  19. Boss EA, van Golde RJ, Beerendonk CC, Massuger LF. Pregnancy after radical trachelectomy: a real option? Gynecol Oncol 2005; 99(3 Suppl 1): S152-6 https://doi.org/10.1016/j.ygyno.2005.07.071
  20. Chiva LM, Lapuente F, Gonzalez-Cortijo L, Gonzalez-Martin A, Rojo A, Garcia JF, Carballo N. Surgical treatment of recurrent cervical cancer: state of the art and new achievements. Gynecol Oncol 2008; 110(3 Suppl 2): S60-6. https://doi.org/10.1016/j.ygyno.2008.05.024
  21. 박재갑, 방영주, 하성환. 종양학. 서울 일조각. 2012. 515-543
  22. Martinez-Monge R , Gaztanaga M, Aramendia JM, Cambeiro M, Arbea L, Espinos J, et al. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer. Int J Gynecol Cancer 2010; 20(1): 133-40. https://doi.org/10.1111/IGC.0b013e3181c057ff
  23. Umayahara K, Takeshima N, Nose T, Fujiwara K, Sugiyama Y, Utsugi K, et al. Phase I study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma in Japanese women. Int J Gynecol Cancer 2009; 19(4): 723-7 https://doi.org/10.1111/IGC.0b013e3181a47b53
  24. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340(15): 1137-43. https://doi.org/10.1056/NEJM199904153401501
  25. 韓磊, 宋艶. 知栢地黃丸的藥理作用和臨床應用硏究進展. 中國藥房. 2012;23(15): 1430-2.
  26. 賀西徵, 盧樂萍, 尹富敏. 知栢地黃湯加味治療腫瘤防療毒副反應23例分析. 中醫藥學刊. 2002;20(4):64-6.
  27. 李瑞, 陳曾燕. 鍼灸聯合藥物保留灌腸治療宮頸癌远期放射性腸炎的效果觀察. 交通醫學. 2008:22(6):711-2
  28. 于玲, 徐蘭 風. 艾葉對宮頸癌放療患子免疫功能的影向. 鍼灸臨床雜誌.2004:20(3):50-2
  29. Thomas GM. Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy. N Engl J Med 1999; 340(15): 1198-200. https://doi.org/10.1056/NEJM199904153401509
  30. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340(15): 1154-61. https://doi.org/10.1056/NEJM199904153401503
  31. Prasad E, Viswanathan PN, Rangad VF, Pavamani S, Ram TS. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix. Clin Oncol (R Coll Radiol) 2009; 21(6): 488-93. https://doi.org/10.1016/j.clon.2009.03.002
  32. Tewari KS, Monk BJ. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group. Semin Oncol 2009; 36(2): 170-80 https://doi.org/10.1053/j.seminoncol.2008.12.008
  33. Haasbeek CJ, Uitterhoeve AL, van der Velden J, Gonzalez DG, Stalpers LJ. Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery. Radiother Oncol 2008 Nov; 89(2): 197-204. https://doi.org/10.1016/j.radonc.2008.01.004
  34. Friedlander M, Grogan M; U.S. Preventative Services Task Force. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist 2002; 7: 342-7.
  35. Dreyer G, Snyman LC, Mouton A, Lindeque BG. Management of recurrent cervical cancer. Best Pract Res Clin Obstet Gynaecol 2005; 19: 631-44. https://doi.org/10.1016/j.bpobgyn.2005.03.003
  36. Wang CJ, Lai CH, Huang HJ, Hong JH, Chou HH, Huang KG, Lin JD. Recurrent cervical carcinoma after primary radical surgery. Am J Obstet Gynecol 1999; 181: 518-24 https://doi.org/10.1016/S0002-9378(99)70486-2
  37. Randall ME, Evans L, Greven KM, McCunniff AJ, Doline RM. Interstitial reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors. Gynecol Oncol 1993 Jan; 48: 23-31. https://doi.org/10.1006/gyno.1993.1005
  38. Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin Radiat Oncol 2006; 16: 144-51 https://doi.org/10.1016/j.semradonc.2006.05.001
  39. Rose PG, Blessing JA, Gershenson DM, et al. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 1999; 17: 2676-80. https://doi.org/10.1200/JCO.1999.17.9.2676
  40. Piver MS, Ghamande SA, Eltabbakh GH, et al. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study. Gynecol Oncol 1999; 75: 334-7. https://doi.org/10.1006/gyno.1999.5586
  41. Papadimitriou CA, Sarris K, Moulopoulos LA, et al. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 1999; 17: 761-6. https://doi.org/10.1200/JCO.1999.17.3.761
  42. Moore DH, Blessing JA, McQuellon RP, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2004; 22: 3113-9. https://doi.org/10.1200/JCO.2004.04.170
  43. Monk BJ, Sill MW, McMeekin DS, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009; 27: 4649-55. https://doi.org/10.1200/JCO.2009.21.8909
  44. Long HJ 3rd, Bundy BN, Grendys EC Jr, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005; 23: 4626-33. https://doi.org/10.1200/JCO.2005.10.021
  45. Fiorica J, Holloway R, Ndubisi B, et al. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix. Gynecol Oncol 2002; 85: 89-94 https://doi.org/10.1006/gyno.2001.6557
  46. Yun YH, Lee MK, Park SM, Kim YA, Lee WJ, Lee KS, et al. Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study. Ann Oncol. 2013:24(2);489-94. https://doi.org/10.1093/annonc/mds469
  47. Amornrat S, Thitima C, Bandit C. Proportion of Gynecologic Cancer Patients Using Complementary and Alternative Medicine. Asian Pacific Journal of Cancer Prevention. 2009: 10;779-82.
  48. Yoshihiro T, Hitoshi I, Kyousuke O, Shunsuke F, Takashi K, Takaharu K, et al. Can Kampo therapy prolong the life of cancer patient? The Journal of Medical Investigation. 2008:55:99-105 https://doi.org/10.2152/jmi.55.99
  49. Vincent CC, Xinyin W, Edwin PH, Eric TZ, Bacon FN, Robin SH, et al. Effectiveness of Chinese herbal medicine for cancer palliative care: overview of systematic reviews with meta-analyses. Scientific Reports. 2015: 5:18111 https://doi.org/10.1038/srep18111
  50. Kim HR, Yoo HS, Beak DG, Park IH, Jang CY, Kim HY, et al. Clinical Practice Guidelines in Korean Medicine for Gastric Cancer. J. Int. Korean Med. 2016:37(1);26-46